A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy

Avani C Modi1, Shanna M Guilfoyle1, Krista A Mann1

  • 1Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.

Epilepsia
|December 24, 2015
PubMed

Insights

A family problem-solving intervention improved antiepileptic drug (AED) adherence in children with new-onset epilepsy. The Supporting Treatment Adherence Regimens (STAR) program showed significant benefits over standard care.

Area of Science:

  • Pediatric Neurology
  • Behavioral Science

Background:

  • Pediatric epilepsy requires consistent antiepileptic drug (AED) adherence for effective management.
  • Poor adherence to AEDs in children with epilepsy can lead to treatment failure and adverse outcomes.
  • Family-centered interventions are crucial for supporting adherence in pediatric chronic conditions.

Purpose of the Study:

  • To evaluate the preliminary efficacy of a family-tailored problem-solving intervention (STAR) for improving AED adherence in children with new-onset epilepsy.
  • To assess the intervention's impact on adherence mechanisms, feasibility, and acceptability.
  • To compare the STAR intervention with Treatment as Usual (TAU).

Main Methods:

  • Fifty families of children with new-onset epilepsy completed baseline assessments and electronic monitoring for AED adherence.
  • Families with adherence ≤95% were randomized to STAR (problem-solving sessions) or TAU.
  • The STAR intervention comprised 4 face-to-face and 2 telephone problem-solving sessions over 8 weeks.

Main Results:

  • Children receiving the STAR intervention showed significantly improved AED adherence compared to the TAU group during active treatment (weeks 4-8).
  • The STAR group demonstrated significant improvements in epilepsy knowledge and management.
  • Families reported positive experiences and benefits from the STAR intervention.

Conclusions:

  • The STAR family problem-solving intervention shows preliminary efficacy in enhancing AED adherence for pediatric epilepsy.
  • The intervention is feasible and acceptable to families, with positive impacts on knowledge and management.
  • Future research should focus on larger samples and booster sessions to sustain adherence improvements.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...